Monday, November 9, 2026

Overcoming the challenges of rare disease clinical research

Tunis, S., Caro, J., Abraham, P. et al. Overcoming the challenges of rare disease clinical research. Orphanet J Rare Dis (2026). doi:10.1186/s13023-026-04668-w 

 This review focuses primarily on clinical development and regulatory evidence-generation strategies for rare diseases, while also highlighting how residual uncertainty may affect subsequent health technology assessment, reimbursement, and access decisions. We provide examples of drug approval processes and outline various potential strategies for clinical development of rare disease treatments, highlighting the strengths of each technique and discussing the opportunities to enhance clinical research.